Steroids Blog

Studies shown by Childhood Asthma Management Program (CAMP) clinical trial reveals that a continued treatment of asthma along with steroids leads to a better result than not using them. The trial as conducted on 1000 children aged between 5-12 and were divided into three groups, out of which one was given the steroid budesonide twice-daily and an inhaled corticosteroid medication; the other received nedocromil, an inhaled non-steroid medication; and third group received a placebo.

From science daily:

Results from the original CAMP trial showed that using budesonide twice daily led to fewer hospitalizations and urgent care visits, fewer days in which additional asthma medications were needed and a reduced need for albuterol, a fast-acting drug for relief of acute asthma symptoms. Using nedocromil twice daily reduced urgent care visits and courses of oral steroids for severe symptoms, but did not affect the number of hospitalizations, symptoms or airway responsiveness.

“The conclusion is that some kids get better, but the doctor, family and the patient have to pay attention to the symptoms,” Strunk said. “Some of the kids are going to need medicine, and they have to be honest about that possibility.”

Though with age, the symptom of asthma is reduced since the patient gets acquainted with the disease and manages on its own whereas it still resides in the body.

As studied by Robert C. Strunk, M.D., a Washington University pediatrician at St. Louis Children’s Hospital and lead author of the study, after five years that Inhaled corticosteroids such as budesonide was most effective form of anti-inflammatory treatment for asthma by controlling symptoms and improving pulmonary function, led to fewer hospitalizations and urgent care visits. Unlike nedocromil twice daily reduced urgent care visits and courses of oral steroids for severe symptoms, but did not affect the number of hospitalizations, symptoms or airway responsiveness.